Bacteria may help treat acne, ulcers
Bacteria that eat ammonia - a major component of sweat - may one day be used to treat acne, ulcers and other skin disorders, say researchers.
Monthly Archives: September 2014
Melanoma drug combo improves patient survival rate, decreases risk of harsh side effect
A UCLA researcher at the Jonsson Comprehensive Cancer Center helped pioneer a new therapy that combines the drug Zelboraf® with an experimental drug cobimetinib, allowing metastatic melanoma...
Sun’s UV radiation rendered harmless by skin pigment
Researchers at Lund University in Sweden and other institutions have worked out how the pigment of the skin manages to protect the body from the sun's dangerous UV rays.
In body-shaping surgery, massive weight loss increases risk of complications
Patients who lost more than 100 pounds and those who shed weight through bariatric surgery had the highest risk of complications from later surgical procedures to reshape their leaner bodies, a new...
Laboratory study confirms burn injury leads overactive cells to generate abnormal bone
An anti-inflammatory treatment, studied in the labs of regenerative medicine specialists and trauma surgeons, may prevent what's become one of the war-defining injuries for today's troops.
Calming down immune cells could hold key to melanoma treatment
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.
Brain areas identified that are activated by itch-relieving drug
Areas of the brain that respond to reward and pleasure are linked to the ability of a drug known as butorphanol to relieve itch, according to new research led by Gil Yosipovitch, MD, Professor and...
Wearable, skin-like device ‘monitors cardiovascular, skin health 24/7’
Researchers have developed a skin-mounted device that can alert wearers to problems with cardiovascular and skin health by detecting temperature changes, according to a new study.
NICE recommendation for Tafinlar® (dabrafenib) for the treatment of metastatic melanoma patients in England and Wales
GlaxoSmithKline (GSK) has announced that the National Institute for Health and Care Excellence (NICE) issued its final appraisal determination (FAD) recommending the use of Tafinlar®...
Combination of phototherapy and afamelanotide results in faster repigmentation in vitiligo patients
Patients with the skin depigmentation disease known as vitiligo had faster and better repigmentation after a combination therapy of the implantable drug afamelanotide and narrowband UV-B (NB-UV-B)...